249A — Human Adjust Co Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 10.81% | ||
| Return on Equity | 35.32% | ||
| Operating Margin | 2.7% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | n/a | n/a | n/a | 1,374.4 | 1,953.19 | n/a | n/a | 42.11% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Human Adjust Co Ltd mainly conducts acupuncture and bonesetter's clinic operation business and store operation. The Company operates in two business segments. The Acupuncture and Bonesetter's Clinic Operation business segment includes the operation of acupuncture and bonesetter's clinics and product sales. The acupuncture and bonesetter's clinic operation business responds to customers such as those with injuries from traffic accidents and the elderly, students with sports injuries, women before and after childbirth, and working adults. Product sales conducts the operation of an e-commerce (EC) site, and sells non-prescription drugs, health foods, and home beauty and health promotion equipment to customers who visit the store. It also introduces EC site systems to outside parties. The Store Operation and Other Support business segment includes store support businesses such as medical care claim agency introduction and operation support and nationally qualified personnel introduction.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- September 14th, 2007
- Public Since
- September 27th, 2024
- No. of Employees
- 266
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Fukuoku Stock Exchange
- Shares in Issue
- 300,000
- Address
- Nishishinjuku 2 Chome 7 Ban 1 Go, SHINJUKU-KU, 163-0725
- Web
- https://human-adjust.co.jp/
- Phone
- +81 362581291
- Auditors
- Cosmos & Co
FAQ
As of Today at 21:10 UTC, shares in Human Adjust Co are trading at ¥1,700. This share price information is delayed by 15 minutes.
Shares in Human Adjust Co last closed at ¥1,700 and the price had moved by over the past 365 days. In terms of relative price strength the Human Adjust Co share price has matched the Nikkei 225 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreHuman Adjust Co does not currently pay a dividend.
Human Adjust Co does not currently pay a dividend.
Human Adjust Co does not currently pay a dividend.
To buy shares in Human Adjust Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of ¥1,700, shares in Human Adjust Co had a market capitalisation of .
Here are the trading details for Human Adjust Co:
- Country of listing: Japan
- Exchange: FKA
- Ticker Symbol: 249A
Based on an overall assessment of its quality, value and momentum Human Adjust Co is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Human Adjust Co. Over the past six months, its share price has matched the Nikkei 225 Index by .
As of the last closing price of ¥1,700, shares in Human Adjust Co were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Human Adjust Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥1,700.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Human Adjust Co's directors